Tiansheng Pharmaceutical Group Co Ltd Class A 002872
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CN¥6.19
- Day Range
- CN¥6.18–6.28
- 52-Week Range
- CN¥4.32–6.28
- Bid/Ask
- CN¥6.22 / CN¥6.25
- Shares Outstanding
- 318.00M
- Market Cap
- CN¥1.99B
- Volume/Avg
- 3M / 3M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.82
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Tiansheng Pharmaceutical Group Co Ltd is a pharmaceutical company. It is engaged in the research, development, production, and sales of pharmaceutical products. The company's business scope covers pharmaceutical manufacturing, circulation, Chinese herbal medicine planting and processing, drug research and development, and others. Its products cover respiratory, digestive, cardiovascular and cerebrovascular, pediatric, gynecological, orthopedic, oncology, hepatobiliary, blood, surgery, diabetes and other systems.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,273
- Website
- http://www.tszy.com.cn
Valuation
|
Metric
|
002872
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.02 |
Price/Sales | 3.82 |
Price/Cash Flow | 21.19 |
Price/Earnings
002872
Financial Strength
|
Metric
|
002872
|
|---|---|
Quick Ratio | 1.12 |
Current Ratio | 1.35 |
Interest Coverage | −3.87 |
Quick Ratio
002872
Profitability
|
Metric
|
002872
|
|---|---|
Return on Assets (Normalized) | −1.36% |
Return on Equity (Normalized) | −1.82% |
Return on Invested Capital (Normalized) | −1.37% |
Return on Assets
002872
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|HX#BpV | LOCK|FKghZ | $128B | |||
| Moderna Inc
MRNA
| LOCK|S$^?@dG | LOCK|^T< | $78B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|#^rKSpL | LOCK|>b&K | $76B | |||
| argenx SE ADR
ARGX
| LOCK|B@GYFJV | LOCK|<^ | $59B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|<Q&!%G@ | LOCK|xQT | $42B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|Ky$Mx!l | LOCK|$K!X# | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|b$&RK!! | LOCK|f^v<Y | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|WvpDyC | LOCK|NQ | $24B | |||
| Incyte Corp
INCY
| LOCK|LFv>@^ | LOCK|&<@ | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|Cyg#LW$ | LOCK|jV? | $15B |
United States